European Companies Search Engine
Company statute Hrb1 Dec 2014 German Trade Register Announcements, Germany
Overview
Text
HRB 504390: STRATEC Biomedical AG, Birkenfeld, Gewerbestr. 37, 75217 Birkenfeld. Due to the conditional increase in the share capital (Conditional Capital I (2007)) decided on May 16, 2007, subscription shares with a par value of EUR 2,800.00 were issued between June 20, 2014 and November 5, 2014; due to the conditional increase in the share capital (Conditional Capital V) decided on May 20, 2009, subscription shares with a par value of EUR 22,400.00 were issued between June 20, 2014 and November 5, 2014. The share capital is thus increased by EUR 25,200.00. On November 24, 2014, the Supervisory Board approved the amendment of the Articles of Association to Section 4 (share capital). EUR 11,795,445.00. The balance of the conditional capital decided on May 16, 2007 (Conditional Capital I (2007)) is still EUR 300.00 after partial exhaustion. The conditional capital (Conditional Capital I/2007) approved at the Annual General Meeting of May 16, 2007 was extinguished by the issuance of subscription shares in the 2014 financial year. The balance of the conditional capital (Conditional Capital V) decided on May 20, 2009 is still EUR 151,350.00 after partial exhaustion.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: STRATEC SE, Birkenfeld, Germany.
The visualizations for "STRATEC Biomedical AG - Company statute"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
